NeoStem Chinese Subsidiary Receives OK from China SFDA to Manufacture Penicilin
NeoStem, Inc. announces it was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent...
View ArticleNeoStem Inc: Expanding Stem Cell Technology into China
NeoStem, Inc (AMEX: NBS) Interview with Dr. Robin Smith, Chairman & CEO
View ArticleNeoStem Provides Business Update
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China, announces a number of business updates.
View ArticleNeoStem Achieves New Milestone as Company Joins Russell 3000 Index
NeoStem, Inc. announces it has been added to the broad-market Russell 3000 Index with Russell Investments' reconstitution of its comprehensive set of U.S. and global equity indexes effective June 25th.
View Article
More Pages to Explore .....